Marizyme, Inc. financial data

Symbol
MRZM on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
555 Heritage Drive, Suite 205, Jupiter, FL
State of incorporation
Nevada
Fiscal year end
December 31
Former names
GBS Enterprises Inc (to 6/27/2018), Swav Enterprises Ltd. (to 8/18/2010)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.32 % -84.7%
Quick Ratio 0.14 % -94.2%
Debt-to-equity -318 % -366%
Return On Assets -206 % -89.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 132M shares
Common Stock, Shares, Outstanding 132M shares +191%
Entity Public Float 3.31M USD -96.6%
Common Stock, Value, Issued 132K USD +191%
Weighted Average Number of Shares Outstanding, Basic 132M shares +205%
Weighted Average Number of Shares Outstanding, Diluted 132M shares +205%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 550K USD -74.5%
Cost of Revenue 158K USD -75.4%
Research and Development Expense 1.51M USD -43.7%
Operating Income (Loss) -30.1M USD +15.6%
Nonoperating Income (Expense) -22.4M USD -78%
Net Income (Loss) Attributable to Parent -52.5M USD -8.84%
Earnings Per Share, Basic -0.98 USD/shares +15.5%
Earnings Per Share, Diluted -0.98 USD/shares +93.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 330K USD -89.6%
Accounts Receivable, after Allowance for Credit Loss, Current 60.3K USD -31.3%
Inventory, Net 26.9K USD -80.8%
Assets, Current 922K USD -12.9%
Property, Plant and Equipment, Net 12.5K USD 0%
Operating Lease, Right-of-Use Asset 899K USD -30.5%
Intangible Assets, Net (Excluding Goodwill) 27.5M USD -47.8%
Goodwill 5.42M USD -24.7%
Assets 21.5M USD -41.8%
Liabilities, Current 23.6M USD +13.1%
Operating Lease, Liability, Noncurrent 460K USD -46.9%
Liabilities 30.9M USD +4.05%
Retained Earnings (Accumulated Deficit) -162M USD -48.1%
Stockholders' Equity Attributable to Parent -9.38M USD -229%
Liabilities and Equity 21.5M USD -41.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -809K USD +27.8%
Net Cash Provided by (Used in) Financing Activities 667K USD -29%
Common Stock, Shares Authorized 2B shares +567%
Common Stock, Shares, Issued 132M shares +191%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -142K USD +21.4%
Deferred Tax Assets, Valuation Allowance 19M USD +34.5%
Deferred Tax Assets, Gross 19.3M USD +32.8%
Operating Lease, Liability 899K USD -30.5%
Lessee, Operating Lease, Liability, to be Paid 928K USD -31.6%
Operating Lease, Liability, Current 440K USD +2.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 266K USD -40.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 445K USD +2.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.6K USD -54.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 266K USD -40.2%
Deferred Tax Assets, Operating Loss Carryforwards 11.7M USD +22.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 266K USD
Additional Paid in Capital 152M USD +30.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 109K USD
Depreciation, Depletion and Amortization 210K USD -0.01%
Share-based Payment Arrangement, Expense 251K USD -71.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%